Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Kopstein

Ophthalmology Tacoma, WA Medical Doctor

NPI 1124050117 CMS profile 231665

502 S M St, Tacoma, WA 98405

Open in the dashboard

General payments

$57,316

110 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Kopstein of Tacoma, WA is reported in the CMS Open Payments database as having received $57,316 across 110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $411 10
2024 General $2,476 15
2023 General $51,977 14
2022 General $487 9
2021 General $900 32
2020 General $381 12
2019 General $682 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Kopstein
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Andrew Kopstein were reported at $411. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Andrew Kopstein Ophthalmology median Middle half National median
2019 $682 $258 $104–$655 $163
2020 $381 $126 $45–$321 $114
2021 $900 $205 $76–$534 $132
2022 $487 $266 $100–$678 $149
2023 $51,977 $308 $117–$745 $160
2024 $2,476 $340 $127–$846 $164
2025 $411 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RxSight Inc $54,107 16 payments
  2. Alcon Vision LLC $2,604 79 payments
  3. TissueTech, Inc. $162 4 payments
  4. Staar Surgical Company $101 1 payment
  5. Johnson & Johnson Surgical Vision, Inc. $97 1 payment
  6. Carl Zeiss Meditec USA, Inc. $56 1 payment
  7. Topcon Healthcare Solutions, Inc. $40 1 payment
  8. Bausch & Lomb Americas Inc. $36 2 payments
  9. AbbVie, Inc. $25 1 payment
  10. Novartis Pharmaceuticals Corporation $25 1 payment
  11. Other $62 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,418 4 payments
  2. Food and Beverage $3,822 103 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,023 1 payment
  4. Gift $27 1 payment
  5. Honoraria $26 1 payment
Products named General payments · program years 2019–2025
  1. RXSIGHT LIGHT DELIVERY DEVICE (LDD) $53,787 14 payments
  2. RXSIGHT CONTACT LENS $53,787 14 payments
  3. RXSIGHT INJECTOR CARTRIDGE $53,787 14 payments
  4. RXSIGHT INJECTOR HANDPIECE $53,787 14 payments
  5. RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL) $51,624 5 payments
  6. LIGHT ADJUSTABLE LENS (LAL) $2,163 9 payments
  7. Clareon $726 16 payments
  8. AcrySof IQ PanOptix Ophthalmology $466 21 payments
  9. LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $320 2 payments
  10. AcrySof IQ PanOptix Ophthalmology $258 9 payments
  11. Other $2,117 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record